PTC Therapeutics Inc (PTCT)
25.37
+0.67
(+2.71%)
USD |
NASDAQ |
Apr 19, 16:00
25.24
-0.13
(-0.51%)
After-Hours: 20:00
PTC Therapeutics Accounts Payable (Quarterly): 6.045M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.045M |
September 30, 2023 | 19.15M |
June 30, 2023 | 25.74M |
March 31, 2023 | 26.31M |
December 31, 2022 | 27.27M |
September 30, 2022 | 20.86M |
June 30, 2022 | 22.88M |
March 31, 2022 | 18.36M |
December 31, 2021 | 23.03M |
September 30, 2021 | 21.46M |
June 30, 2021 | 20.82M |
March 31, 2021 | 19.11M |
December 31, 2020 | 18.66M |
September 30, 2020 | 15.66M |
June 30, 2020 | 15.46M |
March 31, 2020 | 16.07M |
December 31, 2019 | 10.32M |
September 30, 2019 | 8.959M |
June 30, 2019 | 10.22M |
March 31, 2019 | 9.786M |
December 31, 2018 | 6.001M |
September 30, 2018 | 6.538M |
June 30, 2018 | 4.364M |
Date | Value |
---|---|
March 31, 2018 | 3.104M |
December 31, 2017 | 15.28M |
September 30, 2017 | 5.994M |
June 30, 2017 | 6.062M |
March 31, 2017 | 3.579M |
December 31, 2016 | 6.298M |
September 30, 2016 | 19.24M |
June 30, 2016 | 16.80M |
March 31, 2016 | 16.02M |
December 31, 2015 | 5.779M |
September 30, 2015 | 8.715M |
June 30, 2015 | 3.406M |
March 31, 2015 | 3.139M |
December 31, 2014 | 4.128M |
September 30, 2014 | 0.518M |
June 30, 2014 | 0.613M |
March 31, 2014 | 0.387M |
December 31, 2013 | 1.124M |
September 30, 2013 | 1.017M |
June 30, 2013 | 0.4254M |
March 31, 2013 | 0.2693M |
December 31, 2012 | 0.6216M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
6.045M
Minimum
Dec 2023
27.27M
Maximum
Dec 2022
18.23M
Average
19.11M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 164.92M |
Catalyst Pharmaceuticals Inc | 14.80M |
Pfizer Inc | 6.71B |
Geron Corp | 6.161M |
Perspective Therapeutics Inc | 6.107M |